Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy: Basic Science

SPECT and optical multimodality imaging of HIF-active tumors by using an oxygen-dependent degradation protein probe with interchangeable labeling system

Izumi Umeda, Yuu Kakishima, Sadaaki Kimura, Masayuki Yamaguchi, Takahiro Kuchimaru, Shinae Kizaka-Kondoh, Akinori Yanaka and Hirofumi Fujii
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1723;
Izumi Umeda
1National Cancer Center, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuu Kakishima
1National Cancer Center, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sadaaki Kimura
1National Cancer Center, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masayuki Yamaguchi
1National Cancer Center, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takahiro Kuchimaru
2Tokyo Tech, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinae Kizaka-Kondoh
2Tokyo Tech, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akinori Yanaka
3Tokyo Univ. of Science, Noda, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hirofumi Fujii
1National Cancer Center, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1723

Objectives The visualization of hypoxia-inducible factor (HIF)-active tumors is clinically important. We designed a novel in vivo imaging probe for it that consists of protein transduction domain, oxygen-dependent degradation domain, and HaloTag® protein (POH). It can be used as a probe for various imaging modality by differently labeled HaloTag® ligands (HL). We have already succeeded in monitoring HIF-active region in cancers with the near-infrared fluorescently labeled POH probe (NIRF-POH). In this study, we labeled POH with 111In and evaluated their biodistribution in the tumor-bearing mice and their in vivo SPECT images, comparing with NIRF-POH.

Methods HL-DOTA and HL-BnDOTA were synthesized by the reaction of HL-NH2 and NHS-DOTA or p-SCN-BnDOTA, and purified on ODS. They were labeled with 111In, and then conjugated to POH. These radioactive probes were injected i.v. to mice with FM3A or Suit-2 tumors.

Results Both HL-DOTAs were labeled with 111In showing good radiochemical yield (~80%). Conjugation of 111In-HL-DOTAs to POH (111In-POH) was confirmed as a single band around 46 kDa by SDS-PAGE. Their radiochemical purity was over 95%. The biodistribution of 111In-POH was similar to that of NIRF-POH and 111In-POH well accumulated in both tumors (0.8-2.6 % administered dose/g) at 24 h after injection. On in vivo SPECT images, POH was distributed strongly in the liver and kidney, but tumors could be identified at 1h after i.v.. And, as the activities of background areas as well as liver and kidneys gradually decreased, tumors were more clearly visualized at 24 h.

Conclusions 111In-POH showed similar biodistribution to NIRF-POH. And, they could provide quantitative biodistribution data. Moreover, they were clearly imaged on in vivo SPECT for the first time. The SPECT and optical dual imaging system studied here would promote the clinical translation of our HIF imaging strategy established by animal experiments using NIRF-POH

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
SPECT and optical multimodality imaging of HIF-active tumors by using an oxygen-dependent degradation protein probe with interchangeable labeling system
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
SPECT and optical multimodality imaging of HIF-active tumors by using an oxygen-dependent degradation protein probe with interchangeable labeling system
Izumi Umeda, Yuu Kakishima, Sadaaki Kimura, Masayuki Yamaguchi, Takahiro Kuchimaru, Shinae Kizaka-Kondoh, Akinori Yanaka, Hirofumi Fujii
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1723;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
SPECT and optical multimodality imaging of HIF-active tumors by using an oxygen-dependent degradation protein probe with interchangeable labeling system
Izumi Umeda, Yuu Kakishima, Sadaaki Kimura, Masayuki Yamaguchi, Takahiro Kuchimaru, Shinae Kizaka-Kondoh, Akinori Yanaka, Hirofumi Fujii
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1723;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy: Basic Science

  • Modification of chemical structure to improve biodistribution of a radiolabeled sigma ligand for tumor-imaging
  • A Cy5** labelled anti-EGFR affibody selectively targets EGFR in mouse xenograft model
  • Functional analysis of adenoviral induced HSV-TK expression using a breast cancer-specific vs. a non-specific promoter
Show more Oncology: Basic, Translational & Therapy: Basic Science

Basic Science Posters (Oncology)

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • HER2-targeted SPECT imaging of nude mice with colon cancer xenografts using 125I-Herceptin
Show more Basic Science Posters (Oncology)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire